Royal Bank Of Canada Dexcom Inc Put Options Transaction History

Royal Bank Of Canada

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $3.83 Million - $6.94 Million	-59,800 Reduced 89.52%	7,000 $469,000
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $6.82 Million - $8.68 Million	61,800 Added 1236.0%	66,800 $7.57 Million
Q1 2024 Nov 05, 2024	SELL	$114.22 - $140.1 $7.06 Million - $8.66 Million	-61,800 Reduced 92.51%	5,000 $693,000
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $571,100 - $700,500	5,000 New	5,000 $693,000
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $4.91 Million - $7.88 Million	57,100 New	57,100 $5.33 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $77,922 - $97,692	-600 Reduced 50.0%	600 $322,000
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $97,188 - $129,516	1,200 New	1,200 $512,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.